The idyllic island of Nantucket, Massachusetts, faces a persistent threat: Lyme disease. For decades, Dr. Timothy Lepore, the island's sole private physician, has witnessed firsthand the debilitating effects of this tick-borne illness on his patients. Approximately 15% of Nantucket's residents have contracted Lyme, a statistic that underscores the urgency of finding a solution. Now, a team of scientists led by genetic engineering pioneer Kevin Esvelt of MIT, is proposing a radical, yet potentially groundbreaking approach: genetically modifying mice to become immune to Lyme disease.
The problem, as Esvelt explains, stems from a perfect storm of ecological factors. The introduction of deer in 1926, coupled with extensive land conservation in the 1950s, created an ideal breeding ground for ticks and their primary host – the white-footed mouse. These mice, while not directly afflicted by Lyme, serve as crucial vectors, transmitting the bacteria to ticks who then infect humans. This complex ecosystem has fueled a persistent cycle of Lyme disease transmission on the island.
Esvelt and his team at the Sculpting Evolution lab have harnessed the power of CRISPR technology to engineer mice with an inherited immunity to Lyme. By precisely modifying the mouse embryo's DNA, they introduce a gene for an antibody that effectively neutralizes the Lyme bacteria. This modification isn't just temporary; the immunity is passed down through generations, offering a potentially self-sustaining solution.
The plan involves releasing thousands of these genetically modified mice onto Nantucket, strategically timed to coincide with periods of low native mouse populations. The hope is that these Lyme-resistant mice will gradually outcompete their susceptible counterparts, thereby disrupting the disease transmission cycle. While this approach accelerates the process of natural selection, Esvelt acknowledges the ethical considerations inherent in manipulating ecosystems. Extensive community outreach and discussions have been undertaken to address public concerns regarding potential unintended environmental consequences. The project also plans a controlled field trial on a smaller, private island to gather critical data before any large-scale deployment on Nantucket.
While alternative methods, like poisoning the mouse population, exist, they risk disrupting the island's delicate ecosystem. Dr. Lepore, a strong proponent of the genetically modified mice project, highlights the need for thorough testing to prevent unforeseen environmental repercussions. The collaboration between scientists and the Nantucket community reflects a commitment to finding a sustainable and effective solution to a deeply rooted problem, showcasing the potential of cutting-edge science to address complex ecological challenges.
---
Originally published at: https://www.cbsnews.com/news/crispr-modify-mice-target-lyme-disease-60-minutes/
